BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33249395)

  • 1. Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK).
    Nemes K; Bens S; Kachanov D; Teleshova M; Hauser P; Simon T; Tippelt S; Woessmann W; Beck O; Flotho C; Grigull L; Driever PH; Schlegel PG; Khurana C; Hering K; Kolb R; Leipold A; Abbink F; Gil-Da-Costa MJ; Benesch M; Kerl K; Lowis S; Marques CH; Graf N; Nysom K; Vokuhl C; Melchior P; Kröncke T; Schneppenheim R; Kordes U; Gerss J; Siebert R; Furtwängler R; Frühwald MC
    Eur J Cancer; 2021 Jan; 142():112-122. PubMed ID: 33249395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdoid tumors in patients conceived following ART: is there an association?
    Nemes K; Benesch M; Kolarova J; Johann P; Hasselblatt M; Thomas C; Bens S; Glaser S; Ammerpohl O; Liaugaudiene O; Sadeghipour A; von der Weid N; Schmid I; Gidding C; Erdreich-Epstein A; Khurana C; Ebetsberger-Dachs G; Lemmer A; Khatib Z; Hernández Marqués C; Pears J; Quehenberger F; Kordes U; Vokuhl C; Gerss J; Schwarz H; Bison B; Biegel JA; Siebert R; Frühwald MC
    Hum Reprod; 2023 Oct; 38(10):2028-2038. PubMed ID: 37553222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging Population.
    Nemes K; Johann PD; Steinbügl M; Gruhle M; Bens S; Kachanov D; Teleshova M; Hauser P; Simon T; Tippelt S; Eberl W; Chada M; Lopez VS; Grigull L; Hernáiz-Driever P; Eyrich M; Pears J; Milde T; Reinhard H; Leipold A; van de Wetering M; Gil-da-Costa MJ; Ebetsberger-Dachs G; Kerl K; Lemmer A; Boztug H; Furtwängler R; Kordes U; Vokuhl C; Hasselblatt M; Bison B; Kröncke T; Melchior P; Timmermann B; Gerss J; Siebert R; Frühwald MC
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565313
    [No Abstract]   [Full Text] [Related]  

  • 4. The extraordinary challenge of treating patients with congenital rhabdoid tumors-a collaborative European effort.
    Nemes K; Clément N; Kachanov D; Bens S; Hasselblatt M; Timmermann B; Schneppenheim R; Gerss J; Siebert R; Furtwängler R; Bourdeaut F; Frühwald MC;
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26999. PubMed ID: 29418059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007.
    Bartelheim K; Nemes K; Seeringer A; Kerl K; Buechner J; Boos J; Graf N; Dürken M; Gerss J; Hasselblatt M; Kortmann RD; Teichert von Luettichau I; Nagel I; Nygaard R; Oyen F; Quiroga E; Schlegel PG; Schmid I; Schneppenheim R; Siebert R; Solano-Paez P; Timmermann B; Warmuth-Metz M; Frühwald MC
    Cancer Med; 2016 Aug; 5(8):1765-75. PubMed ID: 27228363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors.
    Frühwald MC; Hasselblatt M; Nemes K; Bens S; Steinbügl M; Johann PD; Kerl K; Hauser P; Quiroga E; Solano-Paez P; Biassoni V; Gil-da-Costa MJ; Perek-Polnik M; van de Wetering M; Sumerauer D; Pears J; Stabell N; Holm S; Hengartner H; Gerber NU; Grotzer M; Boos J; Ebinger M; Tippelt S; Paulus W; Furtwängler R; Hernáiz-Driever P; Reinhard H; Rutkowski S; Schlegel PG; Schmid I; Kortmann RD; Timmermann B; Warmuth-Metz M; Kordes U; Gerss J; Nysom K; Schneppenheim R; Siebert R; Kool M; Graf N
    Neuro Oncol; 2020 Jul; 22(7):1006-1017. PubMed ID: 31883020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tisue sarcoma Study Group recommendations.
    Enault M; Minard-Colin V; Corradini N; Leverger G; Thebaud E; Rome A; Proust S; Marie-Cardine A; Defachelles AS; Sarnacki S; Philippe-Chomette P; Delattre O; Masliah-Planchon J; Lacour B; Ferrari A; Brennan B; Orbach D; Bourdeaut F
    Eur J Cancer; 2022 Jan; 161():64-78. PubMed ID: 34929472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
    Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
    Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and Emerging Therapeutic Approaches for Extracranial Malignant Rhabdoid Tumors.
    Nemes K; Johann PD; Tüchert S; Melchior P; Vokuhl C; Siebert R; Furtwängler R; Frühwald MC
    Cancer Manag Res; 2022; 14():479-498. PubMed ID: 35173482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB).
    Bartelheim K; Sumerauer D; Behrends U; Kodetova D; Kucera F; Leuschner I; Neumayer P; Oyen F; Rübe C; Siebert R; Schneppenheim R; Seeringer A; Vasovcak P; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):379-83. PubMed ID: 24972932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Prognostic Characteristics of 53 Cases of Extracranial Malignant Rhabdoid Tumor in Children. A Single-Institute Experience from 2007 to 2017.
    Cheng H; Yang S; Cai S; Ma X; Qin H; Zhang W; Fu L; Zeng Q; Wen M; Peng X; Wang H
    Oncologist; 2019 Jul; 24(7):e551-e558. PubMed ID: 30914466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging therapeutic targets for the treatment of malignant rhabdoid tumors.
    Nemes K; Frühwald MC
    Expert Opin Ther Targets; 2018 Apr; 22(4):365-379. PubMed ID: 29528755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS).
    Kordes U; Bartelheim K; Modena P; Massimino M; Biassoni V; Reinhard H; Hasselblatt M; Schneppenheim R; Frühwald MC
    Pediatr Blood Cancer; 2014 May; 61(5):919-21. PubMed ID: 24123847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor.
    Seeringer A; Reinhard H; Hasselblatt M; Schneppenheim R; Siebert R; Bartelheim K; Leuschner I; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):429-33. PubMed ID: 25262118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis.
    Torchia J; Picard D; Lafay-Cousin L; Hawkins CE; Kim SK; Letourneau L; Ra YS; Ho KC; Chan TS; Sin-Chan P; Dunham CP; Yip S; Ng HK; Lu JQ; Albrecht S; Pimentel J; Chan JA; Somers GR; Zielenska M; Faria CC; Roque L; Baskin B; Birks D; Foreman N; Strother D; Klekner A; Garami M; Hauser P; Hortobágyi T; Bognár L; Wilson B; Hukin J; Carret AS; Van Meter TE; Nakamura H; Toledano H; Fried I; Fults D; Wataya T; Fryer C; Eisenstat DD; Scheineman K; Johnston D; Michaud J; Zelcer S; Hammond R; Ramsay DA; Fleming AJ; Lulla RR; Fangusaro JR; Sirachainan N; Larbcharoensub N; Hongeng S; Barakzai MA; Montpetit A; Stephens D; Grundy RG; Schüller U; Nicolaides T; Tihan T; Phillips J; Taylor MD; Rutka JT; Dirks P; Bader GD; Warmuth-Metz M; Rutkowski S; Pietsch T; Judkins AR; Jabado N; Bouffet E; Huang A
    Lancet Oncol; 2015 May; 16(5):569-82. PubMed ID: 25882982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience.
    Furtwängler R; Kager L; Melchior P; Rübe C; Ebinger M; Nourkami-Tutdibi N; Niggli F; Warmann S; Hubertus J; Amman G; Leuschner I; Vokuhl C; Graf N; Frühwald MC
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28843054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracranial rhabdoid tumours: what we have learned so far and future directions.
    Brennan B; Stiller C; Bourdeaut F
    Lancet Oncol; 2013 Jul; 14(8):e329-36. PubMed ID: 23816299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Influencing Survival of Children with Atypical Teratoid/Rhabdoid Tumors: A Single-Institute Experience in a Developing Country.
    Rao SJB; Konar SK; Shukla D; Bhat DI; Beniwal M; Rao KVLN; Nandeesh BN; Devi BI
    World Neurosurg; 2019 Sep; 129():e264-e272. PubMed ID: 31128308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall Survival of Primary Intracranial Atypical Teratoid Rhabdoid Tumor Following Multimodal Treatment: A Pooled Analysis of Individual Patient Data.
    Ma XJ; Li D; Wang L; Hao SY; Zhang LW; Zhang JT; Wu Z
    Neurosurg Rev; 2020 Feb; 43(1):281-292. PubMed ID: 30535934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Influencing Overall Survival of Children, Adolescents, and Young Adults With High-risk Renal Tumors.
    Islam M; Saltzman AF; Amini A; Carrasco A; Cost NG
    Urology; 2018 Oct; 120():222-230. PubMed ID: 30076944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.